Foghorn Therapeutics filing names BVF Partners group as 10% owner
FHTX•A Form 3 filing reported BVF Partners LP’s group as a 10% owner of Foghorn Therapeutics, with 8,346,168 common shares and warrants for 9,512,297 shares.
1. Ownership filing
The filing lists an event date of Oct. 1, 2026, and reports 8,346,168 common shares held directly across the group’s funds. It also discloses warrants for 9,512,297 shares, including 5,840,979 pre-funded warrants exercisable at $0.0001 per share. Series 1 warrants cover 1,835,659 shares at $13.42 and expire June 30, 2027; Series 2 warrants cover 1,835,659 shares at $20.13 and expire Dec. 31, 2030.
